Market, the Medtronic and Zimmer deal are sold under non Mdxg labels. After 2 years the ramp is slow, hopefully your Stryker deal will move faster.
I listened to most of Interview, Joe Kernan did some homework. Seemed to stay on wound care , bed sores and mentioned a few other areas but I did t hear anything regarding sports. Premarket up 1 buck so we shall see today. Pete seemed very relaxed and did a wonderful job on camera, however he upset 1/2 of ?Georgia by throwing UGA under the bus with his allegiance to GA Tech.
Doc actually buys amniofix for his practice and has seen it work first hand. You can't blame him for cheerleading as he knows the potential not only as an investor, but a Doctor on our board who has put his money where his mouth is.
Listening to Jeffries conference and Bill Taylor just stated they are focusing on International expansion and expect meaningful revenue growth starting in 2016
Rentdmc ,,,the hardest part in investing is waiting, the greatest gains in life can be had by doing what is hard.
Story is unfolding, have faith and patience. I have been here over 5.5 years, and yes, the waiting is difficult.
The fact that injectable is attributing 15 percent of sales with zero marketing and zero mentions in any conference setting is telling. Of course Mdxg can't mention injectables because that is the reason for the untitled letter and knowing the Liberal biased FDA they would find any excuse to send a warning letter out to right wing Pete. This time last year stock was basing near 7, 10 is the new 7. Story is playing out, relax, buy more and enjoy the ride to the buyout.
I wouldn't think the management would want to go into a shareholder meeting with the stock much lower. Would be a good time for a 10 million dollar buy back at 10:59am Thursday morning. :)))
With 17 million short they are holding a nuclear bomb in their hands, at any time we could receive a favorable transition letter for injectable, or we could receive a buyout from 2 to 4 billion. If we were debt ridden, had unseasoned management and a product that had declining sales I could understand the short story. With that said there are plenty of shorts who have been short apple for 4 years, ouch. Mdxg is generating tons of cash, Pete has forecasted 20 percent returns of net profit and ,that cash is going to have to used for something beside hiring more sales people at some near point in the future.
Cicero, it is painfully clear that management is needing to be quiet on the injectable for a reason. As painful as it is to wallow around on light volume don't forget we are up 900 percent from 3 years ago and up over 40 percent give or take from this time last year. I am confident we will arrive at our destination, the journey will be paved with some doubt and fear. With the blanket thrown over this stock because of the liberal agenda of the FDa our gains will probably come in quick bursts . Until then, think of the pain of those who bought at 9 10 and 11, it must be unbearable, which in all of my years of trading unbearable pain in a great company usually results in unbelievable gains. After 5 years of holding I am expecting a short squeeze of all squeezes if the FDA news regarding injectable is favorable. Until the , have comfort with exploding sales, no debt and yes the injectable is a disrupter that will be known by the world soon. My "heart" tells me so, pun intended:)))
Earth, I don't believe this is so much an mdxg story as it is funds dumping biotech in a sector move. Mdxg is part of a few indexes and those funds sell when redemptions hit. Unfortunately mdxg is not that liquid. If the story is truly in tact the stock will recover in time.
Ibb getting hit again today down another 2 percent. Sounds like a good time to buy 9.20 mdxg stock, even for the buy back might be a good way to turbocharge earnings if they can scoop up some cheap shares. Looks like all going according to plan,mas usually happens mr. Market has other plans. This too shall pass, all going according to plan that Pete has announced. Investing can be gut wrenching, that is why trading on margin is so dangerous. Buyout in 2015 is my call above 20 .
How about: I have 6 million reasons why I am happy, thank you mdxg, from your loyal one dollar club. I wrote a book in a past life and used the word idiot about 50 times, it is my weakness. At the end of the day we are all idiots in one way or another, some are just more obvious than others.
I can't believe some on here actually invest real money, or possibly they are just covert shorts. If investors would take the time to read notes from previous conference calls they would quickly learn that Biovance from Alliqua/Cellgene has been around a couple years even before mdxg bought Surgical Biologics. Cellgene actually tried to sell this into the DFU market way back when, and published a small clinical trial in 2009 showing the single layer amnion Biovance only healed 29% of the wounds in 12 weeks, which is about the same as conservative care. Not even remotely close to EpiFix.
Also, Alliqua just bought Celleration, which has MIST therapy, which is directly competitive to Biovance. If Biovance was so good, why in the world would they have purchased MIST? I think that was an overt statement
from them that they know that Biovance can't compete with EpiFix. So in my opinion the headline for this board that biovance would be the downfall is not only factually incompetent, but close to slanderous.
Q1 is always the soft quarter because of the new cms regulations, throw in the weather and we didn't beat. The shorts will try and get you to look at quarter over quarter, don't. Q1 2015 over q1 2014 is over 100 percent growth, that is measurement watched.
FDA clarification close, marketing will begin again on injectable and mdxg will be free from the idiots spreading lies.
I think the lawyers should sue mdxg again because Pete didn't predict the weather and results are only at the upper end of guidance.
Pete Petit has often repeated during conference calls that "no news is good news". With the lack of hardly any news over the past few months, some good news must be boiling over.